Adverse facial edema associated with off-label use of recombinant human bone morphogenetic protein-2 in cranial reconstruction for craniosynostosis: Case report

Journal of Neurosurgery: Pediatrics

Volumn 1, Issue 3, 2008, Pages 255-257

  Shah, M Mohsin ^a   Smyth, Matthew D ^b   Woo, Albert S ^c  

^a University of Missouri   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Bone morphogenetic protein; Craniofacial surgery; Craniosynostosis repair; Metopic synostosis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BONE GRAFT; CASE REPORT; CRANIOFACIAL SURGERY; CRANIOFACIAL SYNOSTOSIS; DEVICE REMOVAL; DISEASE DURATION; DRUG DOSE REDUCTION; FACE EDEMA; FRONTAL BONE; HUMAN; IMMUNE RESPONSE; MALE; OFF LABEL DRUG USE; ORBIT; OSTEOSYNTHESIS; OSTEOSYNTHESIS MATERIAL; PERIORBITAL EDEMA; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN DISEASE; SKULL DEFECT;

BONE MORPHOGENETIC PROTEINS; BONE PLATES; CHILD, PRESCHOOL; CRANIAL SUTURES; CRANIOSYNOSTOSES; CRANIOTOMY; DRUG IMPLANTS; EDEMA; FACIAL DERMATOSES; FRONTAL BONE; HUMANS; MALE; ORBIT; RECOMBINANT PROTEINS; RECONSTRUCTIVE SURGICAL PROCEDURES; SCALP DERMATOSES; TRANSFORMING GROWTH FACTOR BETA;

EID: 40449105644     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/PED/2008/1/3/255     Document Type: Article

References (20)

1. Akita S, Fukui M, Nakagawa H, Fujii T, Akino K: Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen 12:252-259, 2004
2. Canter HI, Isci E: Mandibular reconstruction using a combination graft of rhBMP-2 with bone marrow cells expanded in vitro. Plast Reconstr Surg 118:1663-1664, 2006
3. Chang SC, Chuang H, Chen YR, Yang LC, Chen JK, Mardini S, et al: Cranial repair using BMP-2 gene engineered bone marrow stromal cells. J Surg Res 119:85-91, 2004
4. Haddad AJ, Peel SA, Clokie CM, Sándor GK: Closure of rabbit calvarial critical-sized defects using protective composite allogeneic and alloplastic bone substitutes. J Craniofac Surg 17:926-934, 2006
5. Harwood PJ, Giannoudis PV: Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Expert Opin Drug Saf 4:75-89, 2005
6. Hou R, Chen F, Yang Y, Cheng X, Gao Z, Yang HO, et al: Comparative study between coral-mesenchymal stem cells-rhBMP-2 composite and auto-bone-graft in rabbit critical-sized cranial defect model. J Biomed Mater Res A 80:85-93, 2007
7. Inoda H, Yamamoto G, Hattori T: rh-BMP2-induced ectopic bone for grafting critical size defects: a preliminary histological evaluation in rat calvariae. Int J Oral Maxillofac Surg 36:39-44, 2007
8. Jones AA, Buser D, Schenk R, Wozney J, Cochran DL: The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 77:1184-1193, 2006
9. Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Wozney JM, Wikesjö UM: Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res 18:224-230, 2007
10. Kimura A, Watanabe T, Shimizu T, Okafuji N, Mori R, Furusawa K, et al: Bone repair of rabbit mandibular transsection using rhBMP-2 and atelocollagen gel. Eur J Med Res 11:355-358, 2006
11. Lajeunie E, Le Merrer M, Marchac D, Renier D: Syndromal and nonsyndromal primary trigonocephaly: analysis of a series of 237 patients. Am J Med Genet 75:211-215, 1998
12. Lu DC, Sun PP: Bone morphogenetic protein for salvage fusion in an infant with Down syndrome and craniovertebral instability. Case report. J Neurosurg 106 (6 Suppl):480-483, 2007
13. Mussano F, Ciccone G, Ceccarelli M, Baldi I, Bassi F: Bone morphogenetic proteins and bone defects: a systematic review. Spine 32:824-830, 2007
14. Pang EK, Im SU, Kim CS, Choi SH, Chai JK, Kim CK, et al: Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model. J Periodontol 75:1364-1370, 2004
15. Perri B, Cooper M, Lauryssen C, Anand N: Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 7:235-239, 2007
16. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG: Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31:2813-2819, 2006
17. Springer IN, Acil Y, Kuchenbecker S, Bolte H, Warnke PH, Abboud M, et al: Bone graft versus BMP-7 in a critical size defect - cranioplasty in a growing infant model. Bone 37:563-569, 2005
18. Takahashi Y, Yamamoto M, Yamada K, Kawakami O, Tabata Y: Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 13:293-300, 2007
19. Warren J, Kelly B: FDA Unanimously Recommends Approval of Third Indication For Medtronic's INFUSE Bone Graft. Memphis: Medtronic Media Relations, 2006 (http://www.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId= 1163111450577&format=pdf&lang=en_US) [Accessed 5 November 2007]
20. Zheng YX, Zhao HY, Jing XB, Qin QL, Gu JJ, Tian N, et al: [Reconstruction of orbital floor defect with polylacticglycolide acid/recombinant human bone morphogenetic protein 2 compound implanted material in sheep.] Zhonghua Yan Ke Za Zhi 42:535-539, 2006 (Chn)